SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Mar 6, 2014

AGENUS INC (AGEN) (CIK 0001098972)
Date: March 6, 2014 · CIK: 0001098972 · Accession: 0001193125-14-087025

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-29089

Referenced dates: March 6, 2014

Date
March 6, 2014
Author
/s/ Gerald E. Quirk
Form
CORRESP
Company
AGENUS INC (AGEN) (CIK 0001098972)

Letter

Division of Corporation Finance United States Securities and Exchange Commission Agenus Inc. Preliminary Proxy Statement on Form PRE14A Filed February 27, 2014 (File No. 000-29089)

Re:

Dear Mr. Riedler:

On behalf of Agenus Inc. (the “Company”), we are transmitting for electronic filing via EDGAR pursuant to the Securities Act of 1933, as amended, proposed revisions to the language of the above-referenced proxy statement (the “Proxy Statement”), as originally filed with the Securities and Exchange Commission (the “Commission”) on February 27, 2014. Set forth below is the Company’s response to the comment of the staff of the Securities and Exchange Commission (the “Staff”) in its letter dated March 6, 2014 with respect to the Proxy Statement. For your convenience, the text of the Staff’s comment is set forth in bold below, followed by the Company’s response.

Preliminary Proxy Statement on Form PRE14A

1. Please disclose whether you currently have, or do not have, any plans to issue any of the authorized but unissued shares that would be available as a result of the approval of the amendment to your Amended and Restated Certificate of Incorporation to increase the number of shares of common stock authorized for issuance from 70 million to 140 million. Your current disclosure indicates that you will use the additional authorized but unissued shares to satisfy certain equity awards, and for general business and financial purposes. Your amended disclosure should describe any specific plans that may fall under the category of general business and financial purposes, such as any current agreements or commitments for the issuance of these shares.

Based on the Staff’s comment, the Company has revised the Proxy Statement to state that the Company currently has no specific plans, arrangements or understandings relating to the issuance of any of the Company’s common stock that may fall under the category of general business or financial purposes. The Company has added the following language to the disclosure provided in Proposal 2 at the end of the third paragraph on page 49 of the Proxy Statement:

Other than issuances pursuant to our 2009 Equity Incentive Plan, as of the date of this Proxy Statement we have no plans, arrangements or understandings regarding the issuance of additional shares that would be authorized pursuant to this Proposal 2.

* * *

In addition, please note that the Company has authorized us to inform you that it acknowledges that it is responsible for the adequacy and accuracy of the disclosure in the Proxy Statement; that Staff comments or

Securities and Exchange Commission

March 6, 2014

Page

changes to the disclosure in response to Staff comments in the Proxy Statement do not foreclose the Commission from taking any action with respect to the Proxy Statement, and the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If the proposed changes to the Proxy Statement are acceptable to the Staff, we expect to file the definitive Proxy Statement on Form DEF14A once the comments are cleared or the Staff indicates that we may do so. If the Staff has any questions concerning this letter or requires further information, please do not hesitate to contact Gerald E. Quirk at (617) 248-4817 or Daniel P. Riley at (617) 248-4754.

Sincerely,
/s/ Gerald E. Quirk

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 March 6, 2014

 Jeffrey
P. Riedler, Assistant Director

 Division of Corporation Finance

United States Securities and Exchange Commission

 100 F Street,
N.E.

 Washington, DC 20549-3628

Re:

Agenus Inc.

Preliminary Proxy Statement on Form PRE14A

Filed February 27, 2014

(File No. 000-29089)

 Dear Mr. Riedler:

On behalf of Agenus Inc. (the “Company”), we are transmitting for electronic filing via EDGAR pursuant to the Securities Act
of 1933, as amended, proposed revisions to the language of the above-referenced proxy statement (the “Proxy Statement”), as originally filed with the Securities and Exchange Commission (the “Commission”) on
February 27, 2014. Set forth below is the Company’s response to the comment of the staff of the Securities and Exchange Commission (the “Staff”) in its letter dated March 6, 2014 with respect to the Proxy Statement.
For your convenience, the text of the Staff’s comment is set forth in bold below, followed by the Company’s response.

 Preliminary Proxy
Statement on Form PRE14A

 1. Please disclose whether you currently have, or do not have, any plans to issue any of the
authorized but unissued shares that would be available as a result of the approval of the amendment to your Amended and Restated Certificate of Incorporation to increase the number of shares of common stock authorized for issuance from
70 million to 140 million. Your current disclosure indicates that you will use the additional authorized but unissued shares to satisfy certain equity awards, and for general business and financial purposes. Your amended disclosure should
describe any specific plans that may fall under the category of general business and financial purposes, such as any current agreements or commitments for the issuance of these shares.

Based on the Staff’s comment, the Company has revised the Proxy Statement to state that the Company currently has no specific plans,
arrangements or understandings relating to the issuance of any of the Company’s common stock that may fall under the category of general business or financial purposes. The Company has added the following language to the disclosure provided in
Proposal 2 at the end of the third paragraph on page 49 of the Proxy Statement:

 Other than issuances pursuant to our 2009 Equity
Incentive Plan, as of the date of this Proxy Statement we have no plans, arrangements or understandings regarding the issuance of additional shares that would be authorized pursuant to this Proposal 2.

* * *

 In addition, please note
that the Company has authorized us to inform you that it acknowledges that it is responsible for the adequacy and accuracy of the disclosure in the Proxy Statement; that Staff comments or

Securities and Exchange Commission

 March 6, 2014

 Page
 2

changes to the disclosure in response to Staff comments in the Proxy Statement do not foreclose the Commission from taking any action with respect to the Proxy Statement, and the Company may not
assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If the proposed changes to the Proxy Statement are acceptable to the Staff, we expect to file the definitive Proxy Statement on Form DEF14A
once the comments are cleared or the Staff indicates that we may do so. If the Staff has any questions concerning this letter or requires further information, please do not hesitate to contact Gerald E. Quirk at (617) 248-4817 or Daniel P.
Riley at (617) 248-4754.

Sincerely,

/s/ Gerald E. Quirk

Gerald E. Quirk

cc:

Garo H. Armen, Ph.D.

Chairman and Chief Executive Officer

Agenus Inc.

Karen H. Valentine, Esq.

Vice President and General Counsel

Agenus Inc.